Clinical Trials Logo

11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), clinical trials

View clinical trials related to 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),.

Filter by:
  • None
  • Page 1

NCT ID: NCT01955668 Completed - B Cell Lymphomas Clinical Trials

AZD6738 First Time in Patient Multiple Ascending Dose Study

Start date: November 2013
Phase: Phase 1
Study type: Interventional

In Part A to investigate the safety and tolerability of AZD6738 when given orally to patients with relapsed/refractory CLL, PLL or B cell lymphoma. In Part B to investigate the safety and tolerability of AZD6738 when given orally to patients with prospectively identified 11q deleted or ATM deficient, relapsed/refractory CLL